![Thomas Cirrito](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas P.
Cirrito is the founder of Filament BioSolutions, Inc., serving as Chairman & Chief Executive Officer since 2013.
Dr. Cirrito is the founder of Immunovent LLC, serving as Chief Executive Officer since 2013.
Dr. Cirrito is the founder of Y2x Life Sciences, LLC, serving as Chief Executive Officer since 2020.
Dr. Cirrito was the founder of Biotagenics, Inc., serving as Chief Executive Officer from 2015 to 2020.
Former job at Agelity Biomechanics, Inc. as Chief Executive Officer from 2014 to 2018.
Former job at Stemline Therapeutics, Inc. as Operations Director in 2009.
Former job at Antegrin Therapeutics LLC as Director.
Former job at Indalo Therapeutics, Inc. as Director.
Former job at IN8bio, Inc. as Independent Director from 2016 to 2021.
Education at Washington University in St. Louis with undergraduate and doctorate degrees.
| Sociétés | Poste | Début |
|---|---|---|
Y2x Life Sciences, LLC | Directeur Général | 01/02/2020 |
Filament BioSolutions, Inc.
 Filament BioSolutions, Inc. Pharmaceuticals: OtherHealth Technology Engages in developing of medical and functional foods for diseases | Directeur Général | 01/01/2013 |
Immunovent LLC
 Immunovent LLC Medical/Nursing ServicesHealth Services Operates as a diagnostics center | Directeur Général | 01/01/2013 |
| Sociétés | Poste | Fin |
|---|---|---|
| IN8BIO, INC. | Directeur/Membre du Conseil | 01/01/2021 |
Biotagenics, Inc.
 Biotagenics, Inc. BiotechnologyHealth Technology Develops novel therapeutics and diagnostics | Directeur Général | 01/05/2020 |
Agelity Biomechanics, Inc.
 Agelity Biomechanics, Inc. Medical SpecialtiesHealth Technology Develops medical devices for articular cartilage damage treatments | Directeur Général | 01/05/2018 |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Directeur/Membre du Conseil | - |
Antegrin Therapeutics LLC
 Antegrin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops novel therapies for fibrotic diseases | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 10 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Antegrin Therapeutics LLC
Antegrin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops novel therapies for fibrotic diseases | Health Technology |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Health Technology |
IN8bio, Inc.
 IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Filament BioSolutions, Inc.
Filament BioSolutions, Inc. Pharmaceuticals: OtherHealth Technology Engages in developing of medical and functional foods for diseases | Health Technology |
Immunovent LLC
Immunovent LLC Medical/Nursing ServicesHealth Services Operates as a diagnostics center | Health Services |
Y2x Life Sciences, LLC | |
Biotagenics, Inc.
Biotagenics, Inc. BiotechnologyHealth Technology Develops novel therapeutics and diagnostics | Health Technology |
Agelity Biomechanics, Inc.
Agelity Biomechanics, Inc. Medical SpecialtiesHealth Technology Develops medical devices for articular cartilage damage treatments | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
